Journal Article Summary
The article investigates the effectiveness of dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, compared to metolazone, a thiazide-like diuretic, in treating patients with heart failure who do not respond adequately to loop diuretics. This topic is significant because many patients with heart failure experience diuretic resistance, leading to persistent congestion and worse health outcomes, including longer hospital stays and increased risk of readmission. Understanding whether dapagliflozin can provide better relief from congestion without causing additional kidney issues is crucial for improving treatment strategies in this patient population.
In this study, 61 patients hospitalized for heart failure and resistant to loop diuretics were randomly assigned to receive either dapagliflozin or metolazone for three days. The primary measure of effectiveness was weight loss, which indicates fluid removal, and secondary measures included assessments of lung congestion and kidney function. The results showed that while both medications led to weight loss, the difference was not statistically significant, with dapagliflozin resulting in a mean weight loss of 3.0 kg compared to 3.6 kg for metolazone. Additionally, patients on dapagliflozin required a higher total dose of furosemide but experienced less biochemical disturbance in kidney function and electrolytes.
The study has limitations, including its small sample size and the potential for bias due to its open-label design. Patients and caregivers should be aware that while dapagliflozin may not be more effective than metolazone for relieving congestion, it may cause fewer side effects related to kidney function. It is essential for patients to discuss their treatment options with healthcare professionals, particularly regarding the management of heart failure and the potential benefits and risks of different diuretic therapies.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Yeoh Su Ern, Osmanska Joanna, Petrie Mark C, Brooksbank Katriona J M, Clark Andrew L, Docherty Kieran F, Foley Paul W X, Guha Kaushik, et al.. Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics. European Heart Journal 2023. DOI: 10.1093/eurheartj/ehad341. PMID: 37210742. PMCID: PMC10424881.
Featured Pill Pals Product
Furosemide 40 mg Tablets --- Generic For Lasix --- SOLCO
Furosemide 40 mg Tablets — Generic For Lasix — SOLCO is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
